Hostname: page-component-6766d58669-88psn Total loading time: 0 Render date: 2026-05-21T17:00:58.947Z Has data issue: false hasContentIssue false
  • English
  • Français

Mechanism of action of ketamine

Published online by Cambridge University Press:  18 July 2013

Stephen M. Stahl
Get access Rights & Permissions [Opens in a new window]

Abstract

ISSUE:Ketamine induces rapid-onset and short-duration improvement in depressive and suicidal symptoms in both treatment-resistant unipolar depression and bipolar depression, and also reduces chronic pain after short intravenous infusions. In order to develop long-acting oral agents with the same clinical effects, the pharmacologic mechanism of action must be understood, and the leading hypotheses are discussed here.

Information

Type
Brainstorms
Information
CNS Spectrums , Volume 18 , Issue 4 , August 2013 , pp. 171 - 174
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Stahl, SM. Stahl's Essential Psychopharmacology, 4th ed.New York: Cambridge University Press; 2013.Google Scholar
2.Cateno-Dell'Ossa, M, Gagiolini, A, Rotella, F, Baroni, S, Marazziti, D. Glutamate system as target for development of novel antidepressants. CNS Spectr. in press.Google Scholar
3.Bunney, BG, Bunney, WE. Rapid-acting antidepressant strategies: mechanisms of action. Int J Neuropsychopharmacol. 2012; 15: 695–713.CrossRefGoogle ScholarPubMed
4.Ibrahim, L, Diazgranados, N, Franco-Chaves, J, etal. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology. 2012; 37(6): 1526–1533.CrossRefGoogle ScholarPubMed
5.Li, N, Lee, B, Liu, R-J, etal. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010; 329: 959–964.CrossRefGoogle ScholarPubMed
6.Stahl, SM. The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition? J Clin Psychiatry. 2008; 69: 1673–1674.CrossRefGoogle ScholarPubMed
7.Stahl, SM. Mechanism of action of dextromethorphan/quinidine. CNS Spectr. in press.Google Scholar